Researchers at Vanderbilt Health, including Dr. Edward Siew, and three other centers compared conventional dialysis to a conservative dialysis strategy.

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

The expansion is being led by E. Wesley Ely, MD, MPH and colleagues at the CIBS Center and the Vanderbilt Coordinating Center.

In a paper recently published in Molecular Metabolism, Department of Medicine researchers Drs. Fabian Bock, Nathan Winn, and colleagues, report on findings that could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

Vanderbilt researchers, Drs. Stokes Peebles (Allergy, Pulmonary and Critical Care Medicine), Mark Rusznak and colleagues, have identified free fatty acid receptor 3 (FFAR3), a cell membrane receptor that can “reprogram” inflammatory immune cells, as a potential drug target for treating asthma.

Vanderbilt Health investigators, including Fabien Maldonado, MD, MSc (Allergy, Pulmonary and Critical Care Medicine), have received a grant from AstraZeneca to lead a multisite, randomized controlled trial aimed at refining the standard of care when using robotic bronchoscopy combined with three-dimensional imaging to obtain lung samples for malignancy assessment and gene sequencing.

Two faculty researchers in the Department of Medicine have received Young Physician-Scientist Awards from the American Society for Clinical Investigation (ASCI). Vineet Agrawal, MD, PhD (Cardiovascular Medicine), and Fabian Bock, MD, PhD (Nephrology and Hypertension), are among 50 investigators nationwide selected for the 2026 Young Physician-Scientist Award by the elite honor society.

In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.

Vanderbilt Institute for Global Health researchers, in collaboration with Ugandan partners, have received a $2.5 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study bunyavirus immunity and long-term complications. Paul Blair, MD, MSPH (Infectious Diseases), is a co-investigator of the study.

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.